McKesson

YTD

ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S.

CEO

Brian Scott Tyler

CEOBrian Scott Tyler

Employees

45,000

Employees45,000

Headquarters

Irving, Texas

HeadquartersIrving, Texas

Founded

1833

Founded1833

Employees

45,000

Employees45,000

MCK Key Statistics

Market cap

101.27B

Market cap101.27B

Price-Earnings ratio

25.54

Price-Earnings ratio25.54

Dividend yield

0.37%

Dividend yield0.37%

Average volume

564.56K

Average volume564.56K

High today

$822.36

High today$822.36

Low today

$810.67

Low today$810.67

Open price

$818.48

Open price$818.48

Volume

400.55K

Volume400.55K

52 Week high

$895.58

52 Week high$895.58

52 Week low

$570.51

52 Week low$570.51

Stock Snapshot

The current McKesson(MCK) stock price is $817.98, with a market capitalization of 101.27B. The stock trades at a price-to-earnings (P/E) ratio of 25.54 and offers a dividend yield of 37.3%.

As of 2026-01-24, McKesson(MCK) stock has fluctuated between $810.67 and $822.36. The current price stands at $817.98, placing the stock +0.9% above today's low and -0.5% off the high.

The McKesson(MCK)'s current trading volume is 400.55K, compared to an average daily volume of 564.56K.

In the last year, McKesson(MCK) shares hit a 52-week high of $895.58 and a 52-week low of $570.51.

MCK News

Simply Wall St 21h

A Look At McKesson Valuation As Earnings Growth Expectations And Analyst Optimism Build

McKesson (MCK) is back on investors’ radar as expectations for year-over-year earnings growth ahead of its early February report intersect with its reputation a...

Simply Wall St 2d

McKesson’s CMS Cancer Data Role And What It May Mean For Valuation

McKesson (NYSE:MCK) has been recognized by the Centers for Medicare & Medicaid Services as a Qualified Clinical Data Registry for the tenth consecutive year. C...

Simply Wall St 3d

Does McKesson’s Expanded Oncology Data Role Quietly Reshape Its Long-Term Healthcare Moat?

In January 2026, AOP Health US announced broader U.S. distribution of its critical care beta-blocker Rapiblyk through McKesson, Cardinal, Cencora Specialty Dist...

Analyst ratings

80%

of 20 ratings

Buy

80%

Hold

15%

Sell

More MCK News

TipRanks 4d

McKesson: Expanding Biosimilar and Oncology Platform Drives Incremental Upside and Supports Buy Rating

Analyst Allen Lutz of Bank of America Securities maintained a Buy rating on McKesson, retaining the price target of $950.00. Claim 50% Off TipRanks Premium Unlo...

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.